IP Library › Assignment 039136/0576
Patent Assignment
Reel/Frame 039136/0576

Assignment of Assignor's Interest

Recorded: 2016-07-12 Pages: 5
Assignor
RITTER, GERD
Executed: 2016-06-06
Assignee
LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
STADELHOFERSTRASSE 22, ZURICH, 8001, SWITZERLAND
Covered Property (1)
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Application: 15/166,305 →
Publication: US 2016/0368989
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 12, 2016
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 039136/0571 →
Assignment of Assignor's Interest Jul 12, 2016
From: WILSON, NICHOLAS STUART; SAVITSKY, DAVID ADAM; FINDEIS, MARK ARTHUR
To: AGENUS INC.
Reel/Frame 039136/0516 →
Assignment of Assignor's Interest Jul 12, 2016
From: VAN DIJK, MARC; MUNDT, CORNELIA ANNE
To: 4-ANTIBODY AG
Reel/Frame 039136/0563 →
Assignment of Assignor's Interest Jul 18, 2016
From: WOLCHOK, JEDD DAVID; MERGHOUB, TAHA; SCHAER, DAVID
To: MEMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 039174/0467 →
Security Interest Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Amended and Restated Patent Security Agreement Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Security Interest Mar 31, 2025
From: AGENUS, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 070680/0634 →